Silver Lake Advisory, LLC Bristol Myers Squibb CO Transaction History

Silver Lake Advisory, LLC

$538 Million
Q2 2024

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 23, 2024	BUY	$47.98 - $54.4 $5,949 - $6,745	124 Added 0.43%	29,006 $1.57 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $45,619 - $54,436	-941 Reduced 3.16%	28,882 $1.48 Million
Q3 2023 Oct 25, 2023	SELL	$57.89 - $64.73 $18,814 - $21,037	-325 Reduced 1.08%	29,823 $1.73 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $77,853 - $86,444	-1,222 Reduced 3.9%	30,148 $1.93 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $8,870 - $10,061	135 Added 0.43%	31,370 $2.17 Million

Q4 2022 Jan 30, 2023	BUY	$68.48 - $81.09 $4,725 - $5,595	69 Added 0.22%	31,235 $2.25 Million
Q3 2022 Oct 20, 2022	BUY	$0.13 - $76.84 $9 - $5,455	71 Added 0.23%	31,166 $2.22 Million
Q2 2022 Jul 28, 2022	BUY	$72.62 - $79.98 $5,156 - $5,678	71 Added 0.23%	31,095 $2.39 Million
Q1 2022 May 02, 2022	BUY	$61.48 - $73.72 $4,979 - $5,971	81 Added 0.26%	31,024 $2.27 Million
Q4 2021 Jan 13, 2022	BUY	$53.63 - $62.52 $4,290 - $5,001	80 Added 0.26%	30,943 $1.93 Million
Q2 2021 Aug 04, 2021	SELL	$61.91 - $67.42 $54,109 - $58,925	-874 Reduced 2.75%	30,863 $2.14 Million
Q1 2021 Apr 27, 2021	BUY	$59.34 - $66.74 $70,317 - $79,086	1,185 Added 3.88%	31,737 $2 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $1.76 Million - $1.99 Million	30,490 Added 49177.42%	30,552 $1.9 Million
Q4 2020 Feb 03, 2021	SELL	$57.74 - $65.43 $1.76 Million - $1.99 Million	-30,422 Reduced 99.8%	62 $1.9 Million
Q3 2020 Nov 04, 2020	SELL	$57.43 - $63.64 $77,071 - $85,404	-1,342 Reduced 4.22%	30,484 $1.84 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $8,113 - $9,485	148 Added 0.47%	31,826 $1.87 Million
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $189,776 - $275,788	-4,090 Reduced 11.43%	31,678 $1.77 Million
Q1 2020 Apr 21, 2020	BUY	$46.4 - $67.43 $161,982 - $235,398	3,491 Added 10.82%	35,768 $1.8 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $5,216 - $6,804	106 Added 0.33%	32,277 $2.07 Million
Q3 2019 Oct 21, 2019	BUY	$42.77 - $50.71 $31,093 - $36,866	727 Added 2.31%	32,171 $1.63 Million
Q2 2019 Aug 01, 2019	SELL	$44.62 - $49.34 $16,866 - $18,650	-378 Reduced 1.19%	31,444 $1.43 Million
Q1 2019 Apr 18, 2019	SELL	$45.12 - $53.8 $67.1 Million - $80 Million	-1,486,405 Reduced 97.9%	31,822 $1.52 Million
Q1 2019 Apr 17, 2019	BUY	$45.12 - $53.8 $67.1 Million - $80 Million	1,486,612 Added 4702.24%	1,518,227 $1.52 Million
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $14,579 - $18,905	299 Added 0.95%	31,615 $1.64 Million
Q3 2018 Oct 16, 2018	BUY	$55.19 - $62.25 $37,694 - $42,516	683 Added 2.23%	31,316 $1.94 Million
Q3 2018 Oct 15, 2018	SELL	$55.19 - $62.25 $1,931 - $2,178	-35 Reduced 0.11%	30,633 $1.95 Million
Q2 2018 Jul 16, 2018	SELL	$50.53 - $62.98 $14,148 - $17,634	-280 Reduced 0.9%	30,668 $1.71 Million
Q1 2018 Apr 17, 2018	BUY	$59.92 - $68.98 $9,886 - $11,381	165 Added 0.54%	30,948 $1.96 Million
Q4 2017 Jan 31, 2018	BUY	$59.94 - $65.35 $8,991 - $9,802	150 Added 0.49%	30,783 $1.89 Million
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $1.69 Million - $1.95 Million	30,633	30,633 $1.95 Million

Others Institutions Holding BMY

# of Institutions

2,475

Shares Held

1.49B

Call Options Held

26M

Put Options Held

20M

Vanguard Group Inc Valley Forge, PA

186M
Shares

$9.11 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

163M
Shares

$7.96 Billion
0.21% of portfolio
State Street Corp Boston, MA

91.6M
Shares

$4.49 Billion
0.23% of portfolio
Jpmorgan Chase & CO New York, NY

88.8M
Shares

$4.35 Billion
0.44% of portfolio
Capital International Investors Los Angeles, CA

70.2M
Shares

$3.44 Billion
0.79% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Lake Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silver Lake Advisory, LLC with notifications on news.

Account